It is now possible for individuals to learn about their genetic susceptibility to dozens of common and complex disorders, such as coronary artery disease, diabetes, obesity, prostate cancer, and Alzheimer disease, without ever seeing a physician. Direct-to-consumer personal genome testing companies hope to empower consumers to take control of their health by providing tailored assessments of genetic risk based on reported associations between genomic variation and susceptibility to disease.
McGuire AL, Burke W. An Unwelcome Side Effect of Direct-to-Consumer Personal Genome Testing: Raiding the Medical Commons. JAMA. 2008;300(22):2669–2671. doi:10.1001/jama.2008.803
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: